Stock VRCA VERRICA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Verrica Pharmaceuticals Inc.

Equities

VRCA

US92511W1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
8.78 USD -4.04% Intraday chart for Verrica Pharmaceuticals Inc. +4.15% +19.95%
May. 15 Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth MT
May. 15 Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERRICA PHARMACEUTICALS INC. Stock Verrica Pharmaceuticals Inc.
 388M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 749B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 605B
JOHNSON & JOHNSON Stock Johnson & Johnson
 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 292B
  1. Stock Market
  2. Equities
  3. VRCA Stock
  4. Charts Verrica Pharmaceuticals Inc.
  5. Sector Chart